Recurrent Non-small Cell Lung Cancer Terminated Phase Trials for Docetaxel (DB01248)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

IndicationStatusPhase
DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02145078Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung CancerTreatment